Help us: Donate
Follow us on:
×

Menu

Back

Tag: David Sinclair

Three buildings
Another special purpose acquisition company (SPAC) focused on longevity and rejuvenation biotechnology has appeared recently, and with the addition of research rockstars David Sinclair and Peter Attia, it could mean a bright future for healthy longevity. We recently talked about how SPACs could transform the longevity research industry in Humacyte in Deal to Develop Prosthetic...
Journal Club
The journal club is back for December and we will be discussing the new Sinclair lab paper where researchers have successfully rejuvenated the eyes of aged mice using cellular reprogramming. As some additional background, we recently covered the paper in an article on the news outlet which you can find here. Join us December 22nd...
Mouse eye
Researchers at the Sinclair Lab at Harvard Medical School have restored lost vision to old mice, and mice with damaged retinal nerves, using partial cellular reprogramming. The aged cells can be reset to become younger again using this approach and are better at repairing damaged tissue. The approach has huge potential in the treatment of...
Investment
More and more investors are starting to get interested in technologies that are being developed to slow or even reverse aging as therapies are starting to reach human trials. Recently, I attended the Longevity Investors Conference to learn more about investments being made towards anti-aging research. A shift towards doing something about aging The current...
Covid-19 discussion panel
Yesterday, Dr. David Sinclair, Dr. Aubrey de Grey, Tina Woods, former director of the NIA Dr. Felipe Sierra, Daria Khaltourina, and Lifespan.io president Keith Comito discussed the ongoing COVID-19 pandemic and its relationship to healthcare and the future of aging research. After the discussion, our Lifespan Heroes were able to attend and ask questions as...
Covid-19 panel discussion
On Thursday, May 7th at noon EDT, on our Facebook page, Lifespan.io will be livestreaming an online roundtable discussion with key leaders of our field to discuss the current pandemic, its relationship to aging research, and how the current situation might impact the future of healthcare. Join David Sinclair, Aubrey de Grey, former director of...